Related Experiment Video
Updated: May 10, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
Published on: November 23, 2017
Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells
Dong-Yun Lee1, Cheong-Rae Roh, Young-Hee Kang
1Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Insights
Black cohosh extract increases plasminogen activator inhibitor type 1 (PAI-1) in vascular cells, potentially impairing blood clot breakdown. This suggests a negative cardiovascular effect on fibrinolysis.
Area of Science:
- Cardiovascular Biology
- Pharmacology
- Molecular Biology
Background:
- Black cohosh (Cimicifuga racemosa) is used for menopausal symptoms.
- Cardiovascular effects of black cohosh are not well-studied.
- The plasminogen activator system regulates blood clot breakdown (fibrinolysis).
Purpose of the Study:
- To investigate the effect of black cohosh extract on the plasminogen activator system.
- To examine the impact on vascular smooth muscle cells (VSMCs).
Main Methods:
- VSMCs were isolated from rat aortae.
- Black cohosh extract (BcEx) was applied to cultured VSMCs.
- Protein expression and activity of PAI-1 and t-PA were measured using Western blot, ELISA, and zymography.
Main Results:
- BcEx significantly increased PAI-1 protein expression and activity.
- BcEx did not affect t-PA protein expression but decreased free t-PA activity.
- The effect on PAI-1 was inhibited by Vitamin E, suggesting an oxidant mechanism, and not affected by an estrogen receptor antagonist.
Conclusions:
- Black cohosh extract stimulates PAI-1 expression and activity in VSMCs, likely through an oxidant pathway.
- This action reduces free t-PA, potentially inhibiting fibrinolysis.
- Findings suggest black cohosh may negatively impact cardiovascular health by affecting blood clot breakdown.
Objective:
The rhizome of the Cimicifuga racemosa plant (commonly known as black cohosh) has been used for menopausal complaints. Studies regarding the cardiovascular effects of black cohosh are lacking. We investigated the effect of black cohosh on the plasminogen activator system in cultured vascular smooth muscle cells (VSMCs).
Methods:
VSMCs were isolated from rat aortae. Expression of plasminogen activator inhibitor type 1 (PAI-1) and tissue-type plasminogen activator (t-PA) proteins were evaluated by Western blot analysis and enzyme-linked immunosorbent assay, respectively. The activities of PAI-1 and t-PA in the conditioned media were assessed by fibrin overlay zymography. A 40% 2-propanol extract of black cohosh was used.
Results:
Black cohosh extract (BcEx) stimulated the protein expression of PAI-1, but it did not affect that of t-PA. Vitamin E, a potent antioxidant, inhibited the BcEx-induced increase in PAI-1 expression, while ICI 182,780, an estrogen receptor antagonist, had no effect. Fibrin overlay zymography revealed that BcEx increased the activity of PAI-1 in the conditioned media, while concurrently decreasing that of free t-PA by inducing a binding to PAI-1.
Conclusions:
BcEx induces PAI-1 protein expression in the VSMCs likely via an oxidant mechanism. It also stimulates the enzyme activity of PAI-1 and reduces that of free t-PA. These findings suggest that black cohosh might exert a negative influence on fibrinolysis.
Related Concept Videos
Vascular Spasm
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Atherosclerosis I: Introduction
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antihypertensive Drugs: Action of Calcium Channel Blockers

